US 11291657
Methods of treating inflammatory bowel disease with AMD3100 and Tacrolimus
granted A61KA61K31/00A61K31/365
Quick answer
US patent 11291657 (Methods of treating inflammatory bowel disease with AMD3100 and Tacrolimus) held by MedRegen, LLC expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MedRegen, LLC
- Grant date
- Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/00, A61K31/365, A61K31/395, A61K31/436